BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37365674)

  • 21. Intention-to-treat analysis with treatment discontinuation and missing data in clinical trials.
    Little R; Kang S
    Stat Med; 2015 Jul; 34(16):2381-90. PubMed ID: 25363683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjustment for compliance behavior in trials of epidural analgesia in labor using instrumental variable meta-analysis.
    Bannister-Tyrrell M; Miladinovic B; Roberts CL; Ford JB
    J Clin Epidemiol; 2015 May; 68(5):525-33. PubMed ID: 25592169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian phase II clinical trial design with noncompliance.
    Ren T; Shen W; Zhang L; Zhao H
    Stat Med; 2021 Sep; 40(20):4457-4472. PubMed ID: 34050539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance effects in a randomised controlled trial of yoga for chronic low back pain: a methodological study.
    Tilbrook HE; Hewitt CE; Aplin JD; Semlyen A; Trewhela A; Watt I; Torgerson DJ
    Physiotherapy; 2014 Sep; 100(3):256-62. PubMed ID: 24530169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating causal effects of internet interventions in the context of nonadherence.
    Hesser H
    Internet Interv; 2020 Sep; 21():100346. PubMed ID: 32983907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating the causal effect of milk powder supplementation on bone mineral density: a randomized controlled trial with both non-compliance and loss to follow-up.
    Chen Y; Zhang Q; Wang Y; Xiao Y; Fu R; Bao H; Liu M
    Eur J Clin Nutr; 2015 Jul; 69(7):824-30. PubMed ID: 25626413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multifactorial intervention for frail older people is more than twice as effective among those who are compliant: complier average causal effect analysis of a randomised trial.
    Fairhall N; Sherrington C; Cameron ID; Kurrle SE; Lord SR; Lockwood K; Herbert RD
    J Physiother; 2017 Jan; 63(1):40-44. PubMed ID: 27993489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with telephone-based lifestyle weight loss programs improves low back pain but not knee pain outcomes: complier average causal effects analyses of 2 randomised trials.
    Robson E; Kamper SJ; Lee H; Palazzi K; O'Brien KM; Williams A; Hodder RK; Williams CM
    Pain; 2022 Jul; 163(7):e862-e868. PubMed ID: 34924557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of causal effects in clinical endpoint bioequivalence studies in the presence of intercurrent events: noncompliance and missing data.
    Lou Y; Jones MP; Sun W
    J Biopharm Stat; 2019; 29(1):151-173. PubMed ID: 29995564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implications of noncompliance for randomized trials with partial nesting due to group treatment.
    Roberts C
    Stat Med; 2021 Jan; 40(2):349-368. PubMed ID: 33118193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the ratio of means as a causal estimand in clinical endpoint bioequivalence studies in the presence of intercurrent events.
    Lou Y; Jones MP; Sun W
    Stat Med; 2019 Nov; 38(27):5214-5235. PubMed ID: 31621943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clarifying selection bias in cluster randomized trials.
    Li F; Tian Z; Bobb J; Papadogeorgou G; Li F
    Clin Trials; 2022 Feb; 19(1):33-41. PubMed ID: 34894795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment compliance and effectiveness of a cognitive behavioural intervention for low back pain: a complier average causal effect approach to the BeST data set.
    Knox CR; Lall R; Hansen Z; Lamb SE
    BMC Musculoskelet Disord; 2014 Jan; 15():17. PubMed ID: 24423146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paracetamol is ineffective for acute low back pain even for patients who comply with treatment: complier average causal effect analysis of a randomized controlled trial.
    Schreijenberg M; Lin CC; Mclachlan AJ; Williams CM; Kamper SJ; Koes BW; Maher CG; Billot L
    Pain; 2019 Dec; 160(12):2848-2854. PubMed ID: 31453982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonparametric inference of complier quantile treatment effects in randomized trials with imperfect compliance.
    Mao L
    Biostat Epidemiol; 2022; 6(2):249-265. PubMed ID: 37551295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.